When a pregnant woman reports reduced fetal movements after 28 weeks of gestation, the first step recommended by the RCOG guidelines is to use a handheld Doppler to confirm the fetal heartbeat. If the heartbeat cannot be detected, an ultrasound should be offered immediately. However, if a heartbeat is detected, cardiotocography should be used to monitor the heart rate for 20 minutes. Fetal blood sampling is not necessary in this situation. Referral to a fetal medicine unit would only be necessary if no movements had been felt by 24 weeks.

Understanding Reduced Fetal Movements

Introduction:
Reduced fetal movements can indicate fetal distress and are a response to chronic hypoxia in utero. This can lead to stillbirth and fetal growth restriction. It is believed that placental insufficiency may also be linked to reduced fetal movements.

Physiology:
Quickening is the first onset of fetal movements, which usually occurs between 18-20 weeks gestation and increases until 32 weeks gestation. Multiparous women may experience fetal movements sooner. Fetal movements should not reduce towards the end of pregnancy. There is no established definition for what constitutes reduced fetal movements, but less than 10 movements within 2 hours (in pregnancies past 28 weeks gestation) is an indication for further assessment.

Epidemiology:
Reduced fetal movements affect up to 15% of pregnancies, with 3-5% of pregnant women having recurrent presentations with RFM. Fetal movements should be established by 24 weeks gestation.

Risk factors for reduced fetal movements:
Posture, distraction, placental position, medication, fetal position, body habitus, amniotic fluid volume, and fetal size can all affect fetal movement awareness.

Investigations:
Fetal movements are usually based on maternal perception, but can also be objectively assessed using handheld Doppler or ultrasonography. Investigations are dependent on gestation at onset of RFM. If concern remains, despite normal CTG, urgent (within 24 hours) ultrasound can be used.

Prognosis:
Reduced fetal movements can represent fetal distress, but in 70% of pregnancies with a single episode of reduced fetal movement, there is no onward complication. However, between 40-55% of women who suffer from stillbirth experience reduced fetal movements prior to diagnosis. Recurrent RFM requires further investigations to consider structural or genetic fetal abnormalities.

False labor typically happens during the final month of pregnancy. It is characterized by contractions felt in the lower abdomen that are irregular and spaced out every 20 minutes. However, there are no progressive changes in the cervix.

Labour is divided into three stages, with the first stage beginning from the onset of true labour until the cervix is fully dilated. This stage is further divided into two phases: the latent phase and the active phase. The latent phase involves dilation of the cervix from 0-3 cm and typically lasts around 6 hours. The active phase involves dilation from 3-10 cm and progresses at a rate of approximately 1 cm per hour. In primigravidas, this stage can last between 10-16 hours.

During this stage, the baby’s presentation is important to note. Approximately 90% of babies present in the vertex position, with the head entering the pelvis in an occipito-lateral position. The head typically delivers in an occipito-anterior position.

The appropriate course of action for a woman exhibiting symptoms of agitation and paranoid delusions after giving birth is to admit her to the hospital for urgent assessment. This is likely a case of postpartum psychosis, which is different from postnatal depression. Postpartum psychosis can include mania, depression, irritability, rapid mood changes, confusion, paranoia, delusions, and/or hallucinations. Prescribing medication to aid in sleep is not appropriate in this case, and reassurance that her low mood will improve with time is also not appropriate due to the risk to herself and her baby. Gradual titration of fluoxetine would not manage her acute symptoms and would not ensure the safety of her or her baby. Ideally, she should be hospitalized in a Mother & Baby Unit.

Understanding Postpartum Mental Health Problems

Postpartum mental health problems can range from mild ‘baby-blues’ to severe puerperal psychosis. To screen for depression, healthcare professionals may use the Edinburgh Postnatal Depression Scale, which is a 10-item questionnaire that indicates how the mother has felt over the previous week. A score of more than 13 indicates a ‘depressive illness of varying severity’, with sensitivity and specificity of more than 90%. The questionnaire also includes a question about self-harm.

‘Baby-blues’ is seen in around 60-70% of women and typically occurs 3-7 days following birth. It is more common in primips, and mothers are characteristically anxious, tearful, and irritable. Reassurance and support from healthcare professionals, particularly health visitors, play a key role in managing this condition. Most women with the baby blues will not require specific treatment other than reassurance.

Postnatal depression affects around 10% of women, with most cases starting within a month and typically peaking at 3 months. The features are similar to depression seen in other circumstances, and cognitive behavioural therapy may be beneficial. Certain SSRIs such as sertraline and paroxetine may be used if symptoms are severe. Although these medications are secreted in breast milk, they are not thought to be harmful to the infant.

Puerperal psychosis affects approximately 0.2% of women and requires admission to hospital, ideally in a Mother & Baby Unit. Onset usually occurs within the first 2-3 weeks following birth, and features include severe swings in mood (similar to bipolar disorder) and disordered perception (e.g. auditory hallucinations). There is around a 25-50% risk of recurrence following future pregnancies. Paroxetine is recommended by SIGN because of the low milk/plasma ratio, while fluoxetine is best avoided due to a long half-life.

Chickenpox exposure in pregnancy can pose risks to both the mother and fetus, including fetal varicella syndrome. Post-exposure prophylaxis (PEP) with varicella-zoster immunoglobulin (VZIG) or antivirals should be given to non-immune pregnant women, with timing dependent on gestational age. If a pregnant woman develops chickenpox, specialist advice should be sought and oral acyclovir may be given if she is ≥ 20 weeks and presents within 24 hours of onset of the rash.

To manage a postpartum haemorrhage, an ABC approach should be followed, which involves palpating the uterine fundus and catheterising the patient. In this case, the cause of PPH is uterine atony, which is indicated by risk factors such as induction of labour and multiple pregnancy. The ABCDE approach should be used in all emergency situations, but since the patient is haemodynamically stable, the focus should be on addressing the bleeding. According to RCOG guidelines, pharmacological and mechanical measures should be taken to stop bleeding when uterine atony is the perceived cause. Uterine massage is the most appropriate option in accordance with the guidelines.

Understanding Postpartum Haemorrhage

Postpartum haemorrhage (PPH) is a condition where a woman experiences blood loss of more than 500 ml after giving birth vaginally. It can be classified as primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia.

In managing PPH, it is important to involve senior staff immediately and follow the ABC approach. This includes two peripheral cannulae, lying the woman flat, blood tests, and commencing a warmed crystalloid infusion. Mechanical interventions such as rubbing up the fundus and catheterisation are also done. Medical interventions include IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options such as intrauterine balloon tamponade, B-Lynch suture, ligation of uterine arteries, and hysterectomy may be considered if medical options fail to control the bleeding.

Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to understand the causes and risk factors of PPH to prevent and manage this life-threatening emergency effectively.

When treating allergic rhinitis in pregnant women, loratadine is the recommended first-line oral antihistamine if symptoms are severe enough to require treatment. It is a non-sedative antihistamine with the most available data and no reported teratogenicity. However, it may cause mild sedation, increased appetite, and headaches. If loratadine is ineffective or causes significant side effects, cetirizine or chlorphenamine can be used. Chlorphenamine is a sedative antihistamine and should only be used if other options fail. Nasal sodium cromoglicate spray is safe to use during pregnancy and breastfeeding, but if oral antihistamines are more effective for the patient, it may not be the best option. Oral chlorphenamine is another option, but non-sedative antihistamines should be preferred if they improve symptoms. Leukotriene receptor antagonists like oral montelukast have limited data on their safety in pregnancy and should be avoided unless the benefits outweigh the risks. Pseudoephedrine hydrochloride, a decongestant, should not be used during pregnancy as it can affect uteroplacental circulation and increase the risk of fetal complications.

Safe antihypertensive Medications for Pregnancy

Explanation:
When planning to get pregnant, it is important to ensure that any medications being taken are safe for the developing fetus. In the case of hypertension, switching to a safe medication prior to conception is recommended. Labetalol is the best-studied antihypertensive in pregnancy and is considered safe. Losartan, on the other hand, is contraindicated as it may affect renal development. Simply reducing the dosage of losartan is not enough to mitigate the risks of fetal maldevelopment. It is also important to maintain good blood pressure control prior to conception. Stopping antihypertensive medications abruptly is not recommended as it may lead to uncontrolled hypertension, which is associated with increased fetal loss. By taking these precautions, women can increase their chances of carrying a healthy fetus to term.

Understanding Diabetes Tests During Pregnancy

During pregnancy, it is important for diabetic mothers to have good glycaemic control to prevent complications such as increased miscarriage rate, birth defects, and perinatal mortality. One way to measure glycaemic control is through the HbA1c test, which measures the average blood glucose concentration over the lifespan of a haemoglobin molecule. A level below 6% is considered good. Folic acid supplementation is also important to prevent neural tube defects in the baby.

The 2-hour glucose tolerance test (GTT) is used to screen for diabetes in pregnant women. However, there is no such thing as a 30-minute GTT. Random blood sugar tests only provide a snapshot measurement and do not take into account overall control or other factors that could be affecting sugar levels at that moment. Sugar series tests are not useful for pre-pregnancy counselling as they do not provide information about overall control. Diabetic mothers should be cared for by a joint obstetric-endocrine team of clinicians throughout their pregnancies.

If blood glucose targets are not achieved through diet and metformin in gestational diabetes, insulin should be introduced as the next step. This is in accordance with current NICE guidelines, which recommend that pregnant women with any form of diabetes aim for plasma glucose levels below specific target values. Commencing anti-emetic medications or metformin would not be the most appropriate options in this scenario, as the former would not address the underlying issue of gestational diabetes and the latter is not acceptable to the patient. Additionally, offering a 2 week trial of diet and exercise changes would not be appropriate at this stage, as medication is now required. However, this may be an option for patients with a fasting plasma glucose of between 6.0 and 6.9 mmol/L without complications, who can be offered a trial of diet and exercise for 2 weeks before medication is considered if blood glucose targets are not met.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

Referral to a maternal fetal medicine unit is recommended if there are no fetal movements felt by 24 weeks. While most women feel their baby moving around 18-20 weeks, it can range from 16-24 weeks. If there is a lack of fetal movement, it could be due to various reasons, including miscarriages and stillbirth, which can be distressing. Therefore, it is important to check the fetal heartbeat and consider an ultrasound to detect any abnormalities if no fetal movements are felt by 24 weeks.

Understanding Reduced Fetal Movements

Introduction:
Reduced fetal movements can indicate fetal distress and are a response to chronic hypoxia in utero. This can lead to stillbirth and fetal growth restriction. It is believed that placental insufficiency may also be linked to reduced fetal movements.

Physiology:
Quickening is the first onset of fetal movements, which usually occurs between 18-20 weeks gestation and increases until 32 weeks gestation. Multiparous women may experience fetal movements sooner. Fetal movements should not reduce towards the end of pregnancy. There is no established definition for what constitutes reduced fetal movements, but less than 10 movements within 2 hours (in pregnancies past 28 weeks gestation) is an indication for further assessment.

Epidemiology:
Reduced fetal movements affect up to 15% of pregnancies, with 3-5% of pregnant women having recurrent presentations with RFM. Fetal movements should be established by 24 weeks gestation.

Risk factors for reduced fetal movements:
Posture, distraction, placental position, medication, fetal position, body habitus, amniotic fluid volume, and fetal size can all affect fetal movement awareness.

Investigations:
Fetal movements are usually based on maternal perception, but can also be objectively assessed using handheld Doppler or ultrasonography. Investigations are dependent on gestation at onset of RFM. If concern remains, despite normal CTG, urgent (within 24 hours) ultrasound can be used.

Prognosis:
Reduced fetal movements can represent fetal distress, but in 70% of pregnancies with a single episode of reduced fetal movement, there is no onward complication. However, between 40-55% of women who suffer from stillbirth experience reduced fetal movements prior to diagnosis. Recurrent RFM requires further investigations to consider structural or genetic fetal abnormalities.

Smoking has been found to decrease the risk of hyperemesis gravidarum, which is believed to occur due to rapidly rising levels of human chorionic gonadotropin (HCG) and oestrogen. This is because smoking is considered to be anti-oestrogenic. Therefore, despite having other risk factors, the fact that the patient is a smoker may decrease her incidence of hyperemesis gravidarum. On the other hand, hypothyroidism is not a risk factor, but hyperthyroidism increases the risk of hyperemesis gravidarum. Obesity and underweight are associated with an increased risk of hyperemesis, but women with these conditions who smoked before pregnancy have been found to have no increased risk. Primigravida status is also associated with an increased risk of hyperemesis, but the reason for this is not clear. Finally, twin pregnancies carry an increased risk of hyperemesis gravidarum due to higher levels of beta-hCG released from the placenta.

Hyperemesis gravidarum is an extreme form of nausea and vomiting of pregnancy that occurs in around 1% of pregnancies and is most common between 8 and 12 weeks. It is associated with raised beta hCG levels and can be caused by multiple pregnancies, trophoblastic disease, hyperthyroidism, nulliparity, and obesity. Referral criteria for nausea and vomiting in pregnancy include continued symptoms with ketonuria and/or weight loss, a confirmed or suspected comorbidity, and inability to keep down liquids or oral antiemetics. The diagnosis of hyperemesis gravidarum requires the presence of 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance. Management includes first-line use of antihistamines and oral cyclizine or promethazine, with second-line options of ondansetron and metoclopramide. Admission may be needed for IV hydration. Complications can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth issues.

If a woman with stage IA cervical cancer wants to maintain her fertility, a cone biopsy with negative margins and close follow-up may be considered as the best option. Hysterectomy with or without lymph node clearance would not preserve fertility. Radical trachelectomy, which involves removing the cervix, upper part of the vagina, and surrounding tissues, and checking for cancer spread in the pelvis, is an option for IA2 tumors that also preserves fertility.

Management of Cervical Cancer Based on FIGO Staging

Cervical cancer management is determined by the FIGO staging and the patient’s desire to maintain fertility. The FIGO staging system categorizes cervical cancer into four stages based on the extent of the tumor’s spread. Stage IA and IB tumors are confined to the cervix, with IA tumors only visible under a microscope and less than 7 mm wide. Stage II tumors have spread beyond the cervix but not to the pelvic wall, while stage III tumors have spread to the pelvic wall. Stage IV tumors have spread beyond the pelvis or involve the bladder or rectum.

The management of stage IA tumors involves a hysterectomy with or without lymph node clearance. For patients who want to maintain fertility, a cone biopsy with negative margins can be performed, but close follow-up is necessary. Stage IB tumors are managed with radiotherapy and concurrent chemotherapy for B1 tumors and radical hysterectomy with pelvic lymph node dissection for B2 tumors.

Stage II and III tumors are managed with radiation and concurrent chemotherapy, with consideration for nephrostomy if hydronephrosis is present. Stage IV tumors are treated with radiation and/or chemotherapy, with palliative chemotherapy being the best option for stage IVB. Recurrent disease is managed with either surgical treatment followed by chemoradiation or radiotherapy followed by surgical therapy.

The prognosis of cervical cancer depends on the FIGO staging, with higher survival rates for earlier stages. Complications of treatments include standard surgical risks, increased risk of preterm birth with cone biopsies and radical trachelectomy, and ureteral fistula with radical hysterectomy. Complications of radiotherapy include short-term symptoms such as diarrhea and vaginal bleeding and long-term effects such as ovarian failure and fibrosis of various organs.

The patient has presented with antepartum haemorrhage and ultrasound shows retroplacental haemorrhage, indicating placental abruption. Conservative management is appropriate due to stable vital signs and gestation of 33 weeks. IV corticosteroids are recommended to develop fetal lungs. Tocolysis, category 2 caesarean section, 24-hour cardiotocography monitoring, and planned induction are not indicated. Admission and monitoring are necessary in case of maternal or fetal compromise. Delivery may be required sooner than 3 weeks.

Placental Abruption: Causes, Symptoms, and Risk Factors

Placental abruption is a condition that occurs when the placenta separates from the uterine wall, leading to maternal bleeding into the space between them. Although the exact cause of this condition is unknown, certain factors have been associated with it, including proteinuric hypertension, cocaine use, multiparity, maternal trauma, and increasing maternal age. Placental abruption is not a common occurrence, affecting approximately 1 in 200 pregnancies.

The clinical features of placental abruption include shock that is disproportionate to the visible blood loss, constant pain, a tender and tense uterus, and a normal lie and presentation of the fetus. The fetal heart may be absent or distressed, and there may be coagulation problems. It is important to be aware of other conditions that may present with similar symptoms, such as pre-eclampsia, disseminated intravascular coagulation (DIC), and anuria.

In summary, placental abruption is a serious condition that can have significant consequences for both the mother and the fetus. Understanding the risk factors and symptoms of this condition is important for early detection and appropriate management.

When a pregnant woman with a confirmed DVT is suspected of having a PE, the first step is to immediately administer LMWH to avoid any delay in treatment. PE during pregnancy can be life-threatening for both the mother and the foetus, causing hypoxia and even cardiac arrest. Thrombolysis is not recommended during pregnancy as it can lead to severe haemorrhage in the placenta and foetus. Apixaban is not approved for use during pregnancy and may have teratogenic effects. Similarly, warfarin is not safe during pregnancy and can cause congenital malformations and haemorrhage in the placenta. While a CTPA can be diagnostic, waiting for the scan can be risky for the mother and baby. Therefore, LMWH should be started without delay, and further investigations can be carried out to confirm or rule out a PE.

Investigation of DVT/PE during Pregnancy

Guidelines for investigating deep vein thrombosis (DVT) and pulmonary embolism (PE) during pregnancy were updated in 2015 by the Royal College of Obstetricians. For suspected DVT, compression duplex ultrasound should be performed if there is clinical suspicion. In cases of suspected PE, an ECG and chest x-ray should be performed in all patients. If a woman presents with symptoms and signs of DVT, compression duplex ultrasound should be performed. If DVT is confirmed, no further investigation is necessary, and treatment for venous thromboembolism (VTE) should continue. The decision to perform a ventilation/perfusion (V/Q) scan or computed tomography pulmonary angiography (CTPA) should be made at a local level after discussion with the patient and radiologist.

When comparing CTPA to V/Q scanning in pregnancy, it is important to note that CTPA slightly increases the lifetime risk of maternal breast cancer (up to 13.6%, with a background risk of 1/200 for the study population). Pregnancy makes breast tissue particularly sensitive to the effects of radiation. On the other hand, V/Q scanning carries a slightly increased risk of childhood cancer compared to CTPA (1/50,000 versus less than 1/1,000,000). It is also important to note that D-dimer is of limited use in the investigation of thromboembolism during pregnancy as it is often raised in pregnant women.

Postpartum haemorrhage caused by uterine atony can be treated with various medical options such as oxytocin, ergometrine, carboprost, and misoprostol.

The most common reason for primary postpartum haemorrhage is an atonic uterus. To prevent excessive blood loss, the patient should be advised to receive Syntometrine or oxytocin to stimulate uterine contractions. During the third stage of labour, cord traction should be performed, and the uterus should be massaged after the placenta is delivered. If these measures are ineffective, additional interventions such as blood transfusion and manual removal of the placenta may be necessary. Although breastfeeding can cause uterine contractions, it is not recommended in this case due to the severity of the bleeding.

Understanding Postpartum Haemorrhage

Postpartum haemorrhage (PPH) is a condition where a woman experiences blood loss of more than 500 ml after giving birth vaginally. It can be classified as primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia.

In managing PPH, it is important to involve senior staff immediately and follow the ABC approach. This includes two peripheral cannulae, lying the woman flat, blood tests, and commencing a warmed crystalloid infusion. Mechanical interventions such as rubbing up the fundus and catheterisation are also done. Medical interventions include IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options such as intrauterine balloon tamponade, B-Lynch suture, ligation of uterine arteries, and hysterectomy may be considered if medical options fail to control the bleeding.

Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to understand the causes and risk factors of PPH to prevent and manage this life-threatening emergency effectively.

The correct answer is placenta increta, where the chorionic villi invade the myometrium but not the perimetrium. The patient’s age and history of multiple pregnancies increase the risk of this abnormal placentation, which can be diagnosed through pathological studies. Placenta accreta, percreta, and previa are incorrect answers, as they involve different levels of placental attachment and can cause different symptoms.

Understanding Placenta Accreta

Placenta accreta is a condition where the placenta attaches to the myometrium instead of the decidua basalis, which can lead to postpartum hemorrhage. This condition is caused by a defective decidua basalis. There are three types of placenta accreta, which are categorized based on the degree of invasion. The first type is accreta, where the chorionic villi attach to the myometrium. The second type is increta, where the chorionic villi invade into the myometrium. The third type is percreta, where the chorionic villi invade through the perimetrium.

There are certain risk factors that increase the likelihood of developing placenta accreta, such as having a previous caesarean section or placenta previa. It is important for healthcare providers to be aware of these risk factors and monitor patients closely during pregnancy and delivery. Early detection and management of placenta accreta can help prevent complications and ensure the best possible outcome for both the mother and baby.

If a woman’s Bishop’s score is 8 or higher, it indicates that her cervix is ripe and there is a high likelihood of spontaneous labor or response to labor-inducing interventions. In the case of a woman whose amniotic sac has ruptured but is not yet showing signs of labor, a Bishop’s score can be used to determine the likelihood of spontaneous labor. If her score is 8 or higher, there is no need to intervene and the best course of action is to monitor and reassure her. Inserting a Cook balloon, performing a membrane sweep, or administering an oxytocin infusion would not be appropriate in this situation.

Induction of labour is a process where labour is artificially started and is required in about 20% of pregnancies. It is indicated in cases of prolonged pregnancy, prelabour premature rupture of the membranes, maternal medical problems, diabetic mother over 38 weeks, pre-eclampsia, obstetric cholestasis, and intrauterine fetal death. The Bishop score is used to assess whether induction of labour is necessary and includes cervical position, consistency, effacement, dilation, and fetal station. A score of less than 5 indicates that labour is unlikely to start without induction, while a score of 8 or more indicates a high chance of spontaneous labour or response to interventions made to induce labour.

Possible methods of induction include membrane sweep, vaginal prostaglandin E2, oral prostaglandin E1, maternal oxytocin infusion, amniotomy, and cervical ripening balloon. The NICE guidelines recommend vaginal prostaglandins or oral misoprostol if the Bishop score is less than or equal to 6, while amniotomy and an intravenous oxytocin infusion are recommended if the score is greater than 6.

The main complication of induction of labour is uterine hyperstimulation, which refers to prolonged and frequent uterine contractions that can interrupt blood flow to the intervillous space and result in fetal hypoxemia and acidemia. Uterine rupture is a rare but serious complication. Management includes removing vaginal prostaglandins and stopping the oxytocin infusion if one has been started, and considering tocolysis.

Understanding Polyhydramnios: Excess Amniotic Fluid in Pregnancy

Polyhydramnios is a condition in which there is an excess of amniotic fluid in the second and third trimesters of pregnancy. This excess fluid is produced by the fetal kidneys and is normally swallowed by the fetus. Diagnosis of polyhydramnios is made by ultrasound assessment of the amount of fluid. If the deepest vertical pool is greater than 8 cm or if the amniotic fluid index (AFI) is greater than the 95th percentile for the corresponding gestational age, polyhydramnios is diagnosed.

Polyhydramnios occurs in approximately 2% of all pregnancies and is associated with maternal diabetes and fetal anomalies resulting in gastrointestinal obstruction, such as esophageal atresia and poor fetal swallowing.

It is important to note that normal amniotic fluid varies and increases with gestational age, peaking at around 1 liter. An excess of 2 liters or more is considered consistent with polyhydramnios. Understanding this condition can help healthcare providers monitor and manage pregnancies for the best possible outcomes.

This patient has intrahepatic cholestasis of pregnancy, which is characterized by abnormal liver function tests and severe itching in the third trimester. This condition increases the risk of stillbirth and maternal complications, particularly after 37 weeks of gestation. Therefore, induction of labor is typically recommended at this point, especially for patients with elevated transaminases and bile acids. While increased fetal monitoring is advised, hospitalization is not necessary unless there are signs of immediate concern for the fetus. A vaginal birth is usually appropriate, and a cesarean section is rarely required unless there are indications of non-reassuring fetal status. Although antihistamines can provide symptomatic relief, they are not sufficient on their own due to the risks associated with this condition. Other options for symptom relief include ursodeoxycholic acid, cholestyramine, and topical emollients. There is no indication for immediate delivery, as fetal movements and ultrasound results are normal.

Intrahepatic Cholestasis of Pregnancy: Symptoms and Management

Intrahepatic cholestasis of pregnancy, also known as obstetric cholestasis, is a condition that affects approximately 1% of pregnancies in the UK. It is characterized by intense itching, particularly on the palms, soles, and abdomen, and may also result in clinically detectable jaundice in around 20% of patients. Raised bilirubin levels are seen in over 90% of cases.

The management of intrahepatic cholestasis of pregnancy typically involves induction of labor at 37-38 weeks, although this practice may not be evidence-based. Ursodeoxycholic acid is also widely used, although the evidence base for its effectiveness is not clear. Additionally, vitamin K supplementation may be recommended.

It is important to note that the recurrence rate of intrahepatic cholestasis of pregnancy in subsequent pregnancies is high, ranging from 45-90%. Therefore, close monitoring and management are necessary for women who have experienced this condition in the past.

It should be noted that a significant percentage of women who experience threatened miscarriages will ultimately miscarry. Additionally, it is crucial to consider the possibility of an ectopic pregnancy in pregnant patients who present with both pain and bleeding.

Miscarriage is a common complication that can occur in up to 25% of all pregnancies. There are different types of miscarriage, each with its own set of symptoms and characteristics. Threatened miscarriage is painless vaginal bleeding that occurs before 24 weeks, typically at 6-9 weeks. The bleeding is usually less than menstruation, and the cervical os is closed. Missed or delayed miscarriage is when a gestational sac containing a dead fetus is present before 20 weeks, without the symptoms of expulsion. The mother may experience light vaginal bleeding or discharge, and the symptoms of pregnancy may disappear. Pain is not usually a feature, and the cervical os is closed. Inevitable miscarriage is characterized by heavy bleeding with clots and pain, and the cervical os is open. Incomplete miscarriage occurs when not all products of conception have been expelled, and there is pain and vaginal bleeding. The cervical os is open in this type of miscarriage.

Understanding Pituitary Lesions and their Symptoms

The pituitary gland is a small gland located at the base of the brain that produces and releases hormones that regulate various bodily functions. Lesions in different parts of the pituitary gland can cause a range of symptoms.

Anterior Pituitary: Ischaemic necrosis of the anterior pituitary can occur following post-partum haemorrhage, leading to varying symptoms of hypopituitarism. The most common initial symptom is low or absent prolactin, resulting in failure to commence lactation. Other symptoms may include amenorrhoea, hypothyroidism, glucocorticoid deficiency, and loss of genital and axillary hair. Treatment requires hormone supplementation and involvement of an endocrinologist.

Hypothalamus: Lesions in the hypothalamus can cause hyperthermia/hypothermia, aggressive behaviour, somnolence, and Horner syndrome.

Cerebral Cortex: Lesions in the cerebral cortex are associated with stroke or multiple sclerosis and affect different functions such as speech, movement, hearing, and sight.

Posterior Pituitary: Lesions in the posterior pituitary are associated with central diabetes insipidus.

Pituitary Stalk: Lesions in the pituitary stalk are associated with diabetes insipidus, hypopituitarism, and hyperprolactinaemia. The patient presents with galactorrhoea, irregular menstrual periods, and other symptoms related to hyperprolactinaemia due to the lifting of dopamine neurotransmitter release inhibition.

Measuring Uterine Growth During Pregnancy

During pregnancy, the size of the uterus can be used to estimate the gestational age of the fetus. At around 20 weeks, the uterus reaches the level of the umbilicus. This can be measured using the symphysio-fundal height (SFH), which is usually equal to the number of weeks of gestation (± 2 cm). To measure the SFH, the fundus of the uterus is first palpated and the tape measure is placed at this point. The tape measure is then rolled over the longitudinal axis of the uterus until it reaches the pubic symphysis, and the length in centimeters is recorded.

At 16 weeks, the uterus would not be palpable at the level of the umbilicus. The fundus of the uterus can be palpated at the midpoint between the umbilicus and the pubic symphysis. Similarly, at 18 weeks, the uterus would not be palpable at the level of the umbilicus.

By 22 weeks, the uterus would be past the level of the umbilicus. And by 24 weeks, the uterus would be higher in the abdomen than the umbilicus. Regular measurement of the SFH can help monitor fetal growth and ensure that the pregnancy is progressing normally.

Post-Caesarean Section Complications: Causes and Symptoms

One common complication following a Caesarean section is endometritis, which is characterized by inflammation of the endometrial lining. This condition is usually caused by an infection and can lead to vaginal bleeding. Immediate treatment with antibiotics is necessary to prevent further complications.

Other post-Caesarean section complications that may cause fever include mastitis, wound infections, and haematomas. However, these conditions are not typically associated with prolonged vaginal bleeding.

Retained products of conception are rare following a Caesarean section since the surgical cavity is thoroughly checked during the operation. On the other hand, wound infections and haematomas may cause fever but are not usually accompanied by prolonged vaginal bleeding.

It is important to monitor any symptoms following a Caesarean section and seek medical attention if any complications arise.

It is important for pregnant individuals with type 1 diabetes to closely monitor their blood glucose levels by testing multiple times throughout the day. This is recommended by NICE NG3.

Gestational diabetes is a common medical disorder affecting around 4% of pregnancies. Risk factors include a high BMI, previous gestational diabetes, and family history of diabetes. Screening is done through an oral glucose tolerance test, and diagnostic thresholds have recently been updated. Management includes self-monitoring of blood glucose, diet and exercise advice, and medication if necessary. For pre-existing diabetes, weight loss and insulin are recommended, and tight glycemic control is important. Targets for self-monitoring include fasting glucose of 5.3 mmol/l and 1-2 hour post-meal glucose levels.

Treatment of Cellulitis in Post-Caesarean Section Patient

Cellulitis around the Caesarean wound site requires prompt treatment to prevent the development of sepsis, especially in postpartum women. The initial steps include wound swab for culture and sensitivities, marking the area of cellulitis, and analgesia. Flucloxacillin is the first-line antibiotic for cellulitis, but oral erythromycin is recommended for patients with penicillin allergy. The dose of erythromycin is 500 mg four times a day orally for five to seven days, and it is safe during breastfeeding. Topical treatment is not as effective as systemic treatment, and analgesia is necessary to manage pain. Antibiotics should not be delayed until culture sensitivities are available, and intravenous antibiotics are not indicated unless the patient’s condition deteriorates. Close monitoring of symptoms, observations, and inflammatory markers should guide treatment.

Cardiotocography (CTG) is a medical procedure that measures pressure changes in the uterus using either internal or external pressure transducers. It is used to monitor the fetal heart rate, which normally ranges between 100-160 beats per minute. There are several features that can be observed during a CTG, including baseline bradycardia (heart rate below 100 beats per minute), which can be caused by increased fetal vagal tone or maternal beta-blocker use. Baseline tachycardia (heart rate above 160 beats per minute) can be caused by maternal pyrexia, chorioamnionitis, hypoxia, or prematurity. Loss of baseline variability (less than 5 beats per minute) can be caused by prematurity or hypoxia. Early deceleration, which is a decrease in heart rate that starts with the onset of a contraction and returns to normal after the contraction, is usually harmless and indicates head compression. Late deceleration, on the other hand, is a decrease in heart rate that lags behind the onset of a contraction and does not return to normal until after 30 seconds following the end of the contraction. This can indicate fetal distress, such as asphyxia or placental insufficiency. Variable decelerations, which are independent of contractions, may indicate cord compression.

Immediate Management of Septic Miscarriage: Steps to Take

Septic miscarriage is a life-threatening condition that requires urgent medical attention. If a patient presents with increasing pain, bleeding, and fever, along with clinical signs of sepsis, it is important to inform senior doctors immediately. Here are the steps to take:

1. Call your registrar: Senior doctors need to know about the patient urgently, coming to review and liaising with coordinators to get the patient to theatre as soon as possible.

2. Bloods and blood cultures: This is the most important thing to do after informing seniors. She is already shocked, so getting IV access now is essential. Bloods such as a group and crossmatch need to be sent, along with blood cultures.

3. Transvaginal ultrasound scan: Transvaginal ultrasound scan has no place in the immediate management. The diagnosis is obvious from the history and examination.

4. Ultrasound abdomen: Abdominal ultrasound can be performed after the patient is initially managed and is out of danger. For the current scenario, it is important to inform a senior registrar as the condition may deteriorate. After giving the call to registrar emergency management should be initiated according to A-E assessment.

5. Give analgesia and try to repeat the speculum examination: She is already shocked, and to delay treatment to try and examine again would be dangerous.

By following these steps, you can ensure that the patient receives the urgent care she needs to manage septic miscarriage.

Folic Acid Supplementation for Neural Tube Defect Prevention

Explanation:
Folic acid supplementation is recommended for women who are trying to conceive in order to reduce the risk of neural tube defects and congenital abnormalities in their babies. The recommended dose is 400 μg daily in the preconception period and until the 12th week of gestation. However, women who are identified to be at high risk of having a baby with a neural tube defect should take a higher dose of 5 mg daily, ideally starting in the preconception period and continuing until the 12th week of gestation. It is important to note that folic acid supplementation should be discontinued after the first trimester. Side-effects of folic acid treatment may include abdominal distension, reduced appetite, nausea, and exacerbation of pernicious anaemia. High risk factors for neural tube defects include a family history of neural tube defects, a previous pregnancy affected by a neural tube defect, personal history of neural tube defect, and chronic conditions such as epilepsy and diabetes mellitus.

When a pregnant woman is exposed to chickenpox, it can lead to serious complications for both her and the developing fetus. To prevent this, the first step is to check the woman’s immune status by testing for varicella antibodies. If she is found to be non-immune, she should be given varicella-zoster immune globulin (VZIG) as soon as possible for post-exposure prophylaxis (PEP). This can be arranged by the GP, although the midwife should also be informed.

If the woman is less than 20 weeks pregnant and non-immune, VZIG should be given within 10 days of exposure. If she is more than 20 weeks pregnant and develops chickenpox, oral acyclovir or an equivalent antiviral should be started within 24 hours of rash onset. If the woman is less than 20 weeks pregnant, specialist advice should be sought.

It is important to take action if the woman is found to be non-immune, as providing only reassurance is not appropriate in this situation. By administering VZIG or antivirals, the risk of complications for both the woman and the fetus can be greatly reduced.

Chickenpox exposure in pregnancy can pose risks to both the mother and fetus, including fetal varicella syndrome. Post-exposure prophylaxis (PEP) with varicella-zoster immunoglobulin (VZIG) or antivirals should be given to non-immune pregnant women, with timing dependent on gestational age. If a pregnant woman develops chickenpox, specialist advice should be sought and oral acyclovir may be given if she is ≥ 20 weeks and presents within 24 hours of onset of the rash.

PPH, which is the loss of 500ml or more from the genital tract within 24 hours of giving birth, is primarily caused by uterine atony. It can be classified as minor (500-1000ml) or major (>1000ml) and has a mortality rate of 6 deaths/million deliveries. The causes of PPH can be categorized into the ‘four T’s’: tone, tissue (retained placenta), trauma, and thrombin (coagulation abnormalities).

Understanding Postpartum Haemorrhage

Postpartum haemorrhage (PPH) is a condition where a woman experiences blood loss of more than 500 ml after giving birth vaginally. It can be classified as primary or secondary. Primary PPH occurs within 24 hours after delivery and is caused by the 4 Ts: tone, trauma, tissue, and thrombin. The most common cause is uterine atony. Risk factors for primary PPH include previous PPH, prolonged labour, pre-eclampsia, increased maternal age, emergency Caesarean section, and placenta praevia.

In managing PPH, it is important to involve senior staff immediately and follow the ABC approach. This includes two peripheral cannulae, lying the woman flat, blood tests, and commencing a warmed crystalloid infusion. Mechanical interventions such as rubbing up the fundus and catheterisation are also done. Medical interventions include IV oxytocin, ergometrine, carboprost, and misoprostol. Surgical options such as intrauterine balloon tamponade, B-Lynch suture, ligation of uterine arteries, and hysterectomy may be considered if medical options fail to control the bleeding.

Secondary PPH occurs between 24 hours to 6 weeks after delivery and is typically due to retained placental tissue or endometritis. It is important to understand the causes and risk factors of PPH to prevent and manage this life-threatening emergency effectively.